Oxcarbazepine Tablets 600mg — Class II drug recall D-0085-2023
Terminated recall by SUN PHARMACEUTICAL INDUSTRIES INC, reported 2022-12-28, distributed nationwide. Presence of foreign substance
| Recall number | D-0085-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC, Princeton, NJ, United States |
| Recall initiated | 2022-12-01 |
| Classified | 2022-12-19 |
| Reported by FDA | 2022-12-28 |
| Terminated | 2023-09-13 |
| Distributed | Nationwide (US) |
| NDC | 62756-0183, 62756-0183-08, 62756-0183-13, 62756-0183-18, 62756-0183-83, 62756-0183-88, 62756-0184, 62756-0184-08, 62756-0184-13, 62756-0184-18, 62756-0184-83, 62756-0184-88, 62756-0185, 62756-0185-08, 62756-0185-13, 62756-0185-18, 62756-0185-83, 62756-0185-88 |
| Lot numbers | HAC1474A, HAC1474B, HAC1503A |
| Expiration dates | 2023-03 |
Product
Oxcarbazepine Tablets 600mg, packaged in a) 100- count bottles (NDC 62756-185-88), b) 500-count bottles (NDC 62756-185-13), c)1000-count bottles (NDC 62756-185-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Halol-Baroda Highway, Halol-389 350, Gujarat, India.
Reason for recall
Presence of foreign substance
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0085-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.